4//SEC Filing
SCHAFER GREGORY W 4
Accession 0001209191-17-059859
CIK 0001435049other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 8:01 PM ET
Size
13.0 KB
Accession
0001209191-17-059859
Insider Transaction Report
Form 4
SCHAFER GREGORY W
Chief Operating Officer
Transactions
- Exercise/Conversion
Common Stock
2017-11-06$1.45/sh+6,932$10,051→ 155,677 total - Exercise/Conversion
Common Stock
2017-11-06$0.82/sh+13,068$10,716→ 168,745 total - Exercise/Conversion
Stock Option (right to buy)
2017-11-06−6,932→ 106,676 totalExercise: $1.45Exp: 2025-01-09→ Common Stock (6,932 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-11-06−13,068→ 215,459 totalExercise: $0.82Exp: 2023-11-26→ Common Stock (13,068 underlying) - Sale
Common Stock
2017-11-06$7.97/sh−20,000$159,312→ 148,745 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.80 to $8.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of January 10, 2015.
- [F4]The shares subject to the Option became fully vested and exercisable as of July 1, 2017.
Documents
Issuer
ADURO BIOTECH, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001193195
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 8:01 PM ET
- Size
- 13.0 KB